एपीए उद्धरण

Watt, M., McCrea, C., Johal, S., Posnett, J., & Nazir, J. (2016). A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany. Infection.

शिकागो स्टाइल उद्धरण

Watt, Maureen, Charles McCrea, Sukhvinder Johal, John Posnett, और Jameel Nazir. "A Cost-effectiveness and Budget Impact Analysis of First-line Fidaxomicin for Patients With Clostridium Difficile Infection (CDI) in Germany." Infection 2016.

एमएलए उद्धरण

Watt, Maureen, et al. "A Cost-effectiveness and Budget Impact Analysis of First-line Fidaxomicin for Patients With Clostridium Difficile Infection (CDI) in Germany." Infection 2016.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.